Catalina Raymond Selected Research

Catalina Raymond Research Topics

Disease

26	Neoplasms (Cancer) 10/2023 - 10/2017
19	Glioma (Gliomas) 06/2023 - 09/2018
13	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 10/2017
5	Brain Neoplasms (Brain Tumor) 10/2023 - 11/2018
3	Hypoxia (Hypoxemia) 01/2022 - 01/2019
1	Astrocytoma (Pilocytic Astrocytoma) 01/2024
1	Necrosis 06/2023
1	Schizophrenia (Dementia Praecox) 01/2020
1	Acidosis 01/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019

Drug/Important Bio-Agent (IBA)

9	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2024 - 01/2019
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2017
8	AminesIBA 10/2023 - 11/2018
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 10/2017
5	Oxygen (Dioxygen)IBA 05/2022 - 11/2018
5	fluorodopa F 18IBA 05/2021 - 09/2018
4	Protons (Proton)IBA 06/2023 - 11/2018
4	Bevacizumab (Avastin)FDA Link 01/2021 - 10/2018
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
3	Phenylalanine (L-Phenylalanine)FDA Link 09/2021 - 09/2020
2	Amino Acids FDA Link 01/2023 - 01/2021
2	MethyltransferasesIBA 01/2023 - 10/2018
2	Temozolomide (Temodar)FDA LinkGeneric 10/2022 - 10/2018
2	ErbB Receptors (EGF Receptor)IBA 05/2022 - 06/2021
2	HexokinaseIBA 01/2022 - 01/2021
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2022 - 01/2021
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2020
1	GadoliniumIBA 10/2023
1	Angiogenesis InhibitorsIBA 10/2023
1	Erythropoietin FDA Link 10/2023
1	PT2385IBA 10/2023
1	SodiumIBA 06/2023
1	Immune Checkpoint InhibitorsIBA 01/2022
1	EnzymesIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	GDC-0084IBA 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	DecorinIBA 01/2020
1	thiamine triphosphorate (TTP)IBA 03/2019
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Proto-Oncogene Proteins c-metIBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	cabozantinibIBA 01/2018
1	Lomustine (CCNU)FDA Link 10/2017

Therapy/Procedure

8	Therapeutics 10/2023 - 10/2017
2	Aftercare (After-Treatment) 01/2023 - 01/2022
1	Injections 10/2023
1	Lasers (Laser) 08/2023
1	Immunotherapy 01/2023
1	Drug Therapy (Chemotherapy) 01/2023